Mehdi Rasouli

1.2k total citations
41 papers, 919 citations indexed

About

Mehdi Rasouli is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, Mehdi Rasouli has authored 41 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Mehdi Rasouli's work include Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Lipoproteins and Cardiovascular Health (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Mehdi Rasouli is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Lipoproteins and Cardiovascular Health (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Mehdi Rasouli collaborates with scholars based in Iran, United States and Canada. Mehdi Rasouli's co-authors include Richard Lehner, Babak Bagheri, Dennis E. Vance, Samuel B. Ho, Matthew J. Budoff, Dean Gilham, David M. Shavelle, Robert Park, Roger S. Blumenthal and Khurram Nasir and has published in prestigious journals such as Journal of the American College of Cardiology, The FASEB Journal and The American Journal of Cardiology.

In The Last Decade

Mehdi Rasouli

39 papers receiving 884 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mehdi Rasouli Iran 20 193 186 168 168 163 41 919
Zehra Serdar Türkiye 21 169 0.9× 134 0.7× 163 1.0× 139 0.8× 156 1.0× 71 1.3k
Claudine Cosson France 19 289 1.5× 271 1.5× 196 1.2× 164 1.0× 157 1.0× 46 978
Mehmet Şeneş Türkiye 18 188 1.0× 132 0.7× 185 1.1× 73 0.4× 191 1.2× 78 928
Oya Bayındır Türkiye 19 118 0.6× 121 0.7× 255 1.5× 112 0.7× 85 0.5× 44 936
Dimitrios Tousoulis Greece 19 314 1.6× 409 2.2× 138 0.8× 203 1.2× 199 1.2× 43 1.1k
Özkan Alataş Türkiye 21 198 1.0× 97 0.5× 218 1.3× 95 0.6× 141 0.9× 67 1.2k
Mehmet Horoz Türkiye 20 210 1.1× 80 0.4× 138 0.8× 66 0.4× 243 1.5× 48 1.1k
Ciprian Rezuș Romania 17 124 0.6× 176 0.9× 302 1.8× 58 0.3× 111 0.7× 84 1.1k
Qinghua Wu China 22 223 1.2× 324 1.7× 436 2.6× 109 0.6× 188 1.2× 108 1.5k
Chiara Mozzini Italy 19 149 0.8× 217 1.2× 348 2.1× 76 0.5× 166 1.0× 47 1.2k

Countries citing papers authored by Mehdi Rasouli

Since Specialization
Citations

This map shows the geographic impact of Mehdi Rasouli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehdi Rasouli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehdi Rasouli more than expected).

Fields of papers citing papers by Mehdi Rasouli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehdi Rasouli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehdi Rasouli. The network helps show where Mehdi Rasouli may publish in the future.

Co-authorship network of co-authors of Mehdi Rasouli

This figure shows the co-authorship network connecting the top 25 collaborators of Mehdi Rasouli. A scholar is included among the top collaborators of Mehdi Rasouli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehdi Rasouli. Mehdi Rasouli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rasouli, Mehdi, et al.. (2021). Investigation of Antioxidant Status in Coronary Artery Disease Patients. 1(1). 2 indexed citations
2.
Rasouli, Mehdi, et al.. (2020). Hypolipemic effects of histamine is due to inhibition of VLDL secretion from the liver: involvement of both H1 and H2-receptors. Archives of Physiology and Biochemistry. 128(6). 1566–1570. 3 indexed citations
3.
Bagheri, Babak, et al.. (2018). Esterification of HDL cholesterol is Decreased in Diabetes Mellitus and CAD and Enhanced Following Treatment with Statins. Medical Archives. 72(3). 197–197. 4 indexed citations
4.
Bagheri, Babak, et al.. (2018). The Ratio of Unesterified/esterified Cholesterol is the Major Determinant of Atherogenicity of Lipoprotein Fractions. Medical Archives. 72(2). 103–103. 14 indexed citations
5.
Bahreyni, Amirhossein, Rezvan Yazdian‐Robati, Mohammad Ramezani, et al.. (2017). Identification and imaging of leukemia cells using dual-aptamer-functionalized graphene oxide complex. Journal of Biomaterials Applications. 32(1). 74–81. 20 indexed citations
6.
Rasouli, Mehdi, et al.. (2016). Improvement of the classical assay method for liver glycogen fractions: ASG is the main and metabolic active fraction.. PubMed. 20(20). 4328–4336. 7 indexed citations
7.
Rasouli, Mehdi. (2016). The Long Term Kinetic of Plasma Lipids and Lipoproteins in Tyloxapol Injected Rats. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. 10(6). BF01–5. 17 indexed citations
8.
Rasouli, Mehdi, et al.. (2016). Calculation of LDL‐Cholesterol vs. Direct Homogenous Assay. Journal of Clinical Laboratory Analysis. 31(3). 22 indexed citations
9.
Rasouli, Mehdi. (2016). Basic concepts and practical equations on osmolality: Biochemical approach. Clinical Biochemistry. 49(12). 936–941. 121 indexed citations
10.
Rasouli, Mehdi, et al.. (2015). A new protocol for separation of acid soluble and insoluble fractions from total glycogen and simultaneous measurements.. PubMed. 19(10). 1785–9. 8 indexed citations
11.
Rasouli, Mehdi, et al.. (2009). Microalbuminuria correlates with the prevalence and severity of coronary artery disease in non-diabetic patients.. PubMed. 16(2). 142–5. 16 indexed citations
12.
Rasouli, Mehdi, et al.. (2008). INDICATORS OF DEHYDRATION AND HAEMOCONCENTRATION ARE ASSOCIATED WITH THE PREVALENCE AND SEVERITY OF CORONARY ARTERY DISEASE. Clinical and Experimental Pharmacology and Physiology. 35(8). 889–894. 27 indexed citations
13.
Rasouli, Mehdi, et al.. (2008). Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease. Clinical Chemistry and Laboratory Medicine (CCLM). 46(5). 667–73. 23 indexed citations
14.
Budoff, Matthew J., Mehdi Rasouli, David M. Shavelle, et al.. (2007). Cardiac CT Angiography (CTA) and Nuclear Myocardial Perfusion Imaging (MPI)—A Comparison in Detecting Significant Coronary Artery Disease. Academic Radiology. 14(3). 252–257. 28 indexed citations
15.
Rasouli, Mehdi, et al.. (2006). The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease. Clinical Chemistry and Laboratory Medicine (CCLM). 44(8). 42 indexed citations
16.
Behzad‐Behbahani, Abbas, Seyed Ziaeddin Tabei, Kamran Bagheri Lankarani, et al.. (2005). Indication of Anti-HBc Antibody Screening and HBV-DNA Detection in Diagnosing Latent Hepatitis B Virus Infection. Iranian journal of medical sciences. 30(1). 28–33. 8 indexed citations
17.
Rasouli, Mehdi, Khurram Nasir, Roger S. Blumenthal, et al.. (2005). Plasma homocysteine predicts progression of atherosclerosis. Atherosclerosis. 181(1). 159–165. 67 indexed citations
18.
Shavelle, David M., Mehdi Rasouli, Frederick A. Spencer, C. Michael Gibson, & William J. French. (2005). Outcome in Patients Transferred for Percutaneous Coronary Intervention (A National Registry of Myocardial Infarction 2/3/4 Analysis). The American Journal of Cardiology. 96(9). 1227–1232. 40 indexed citations
19.
Rasouli, Mehdi, et al.. (2005). Comparison of methods for calculating serum osmolality: multivariate linear regression analysis. Clinical Chemistry and Laboratory Medicine (CCLM). 43(6). 635–40. 59 indexed citations
20.
Rasouli, Mehdi, et al.. (2004). Calmodulin antagonist W-7 inhibits de novo synthesis of cholesterol and suppresses secretion of de novo synthesized and preformed lipids from cultured hepatocytes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1682(1-3). 92–101. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zehra Serdar Breakdown of academic impact, for papers by Claudine Cosson Breakdown of academic impact, for papers by Mehmet Şeneş Breakdown of academic impact, for papers by Oya Bayındır Breakdown of academic impact, for papers by Dimitrios Tousoulis Breakdown of academic impact, for papers by Özkan Alataş Breakdown of academic impact, for papers by Mehmet Horoz Breakdown of academic impact, for papers by Ciprian Rezuș Breakdown of academic impact, for papers by Qinghua Wu Breakdown of academic impact, for papers by Chiara Mozzini
Rankless by CCL
2026